Open-label Extension of the HOPE-2 Trial

NCT04428476 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

BIOLOGICAL: Deramiocel (CAP-1002)

Sponsor

Capricor Inc.